- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Fulgent Genetics Inc (FLGT)
Fulgent Genetics Inc stock price live, this page displays NASDAQ FLGT stock exchange data. View the FLGT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Fulgent Genetics Inc real time stock price chart below.
What Is the Fulgent Genetics Inc Stock Price Today?
The Fulgent Genetics Inc stock price today is 19.15.
What Is the Stock Symbol for Fulgent Genetics Inc?
The stock symbol for Fulgent Genetics Inc is "FLGT."
What Stock Exchange Does Fulgent Genetics Inc Trade On?
Fulgent Genetics Inc is listed and trades on the NASDAQ stock exchange.
Is Fulgent Genetics Inc a Good Stock to Buy?
Determining whether Fulgent Genetics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the FLGT quote. (ISIN: US3596641098)
What Is the Fulgent Genetics Inc Stock Price Today?
The Fulgent Genetics Inc stock price today is 19.15.
What Is the Stock Symbol for Fulgent Genetics Inc?
The stock symbol for Fulgent Genetics Inc is "FLGT."
What Stock Exchange Does Fulgent Genetics Inc Trade On?
Fulgent Genetics Inc is listed and trades on the NASDAQ stock exchange.
Is Fulgent Genetics Inc a Good Stock to Buy?
Determining whether Fulgent Genetics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the FLGT quote. (ISIN: US3596641098)
19.15
+0.09(+0.47%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
19.03
19.28
52 wk Range
13.46
31.04
FLGT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
19.0319.28
52 wk Range
13.4631.04
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
FLGT Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Neutral
Price Target
19.00
Downside
-0.78%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Holds more cash than debt on its balance sheet
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 19.00
(-0.78% Downside)
Fulgent Genetics Inc Earnings Call Summary for Q2/2026
- Fulgent Genetics missed Q2 estimates with adjusted loss of $0.58/share vs. $0.44 expected; revenue of $85.4M fell short of $91.77M consensus.
- Stock plunged 16.87% after-hours to $16.80 following reduced 2026 revenue guidance to $330-340M from $350M due to billing system issues.
- Billing and revenue cycle management transition delayed claims processing, lowering collection rates below historical norms and pressuring results.
- Anatomopathology revenue surged 33% YoY to $37.5M on acquisitions, while precision diagnostics declined 13% YoY amid customer in-sourcing.
- FDA end-of-phase-two meeting for FID-007 scheduled summer 2026; phase-three registration trial expected first half 2027 per CEO Ming Hsieh.
Last Updated: 2026-07-30, 05:16 p/m
Read Full TranscriptEarnings
Latest Release
Jul 30, 2026
EPS / Forecast
-0.58 / -0.44
Revenue / Forecast
85.4M / 91.77M
Compare FLGT to Peers and Sector
Metrics to compare | FLGT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipFLGTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.2x | −50.2x | −0.4x | |
PEG Ratio | 0.09 | 0.77 | 0.00 | |
Price/Book | 0.5x | 5.4x | 2.6x | |
Price / LTM Sales | 1.6x | 2.9x | 3.1x | |
Upside (Analyst Target) | −0.3% | 16.9% | 48.2% | |
Fair Value Upside | Unlock | −15.8% | 5.8% | Unlock |
Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company’s clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, large corporations, and patients. Fulgent Genetics, Inc. was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. The company was founded in 2011 and is headquartered in El Monte, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Fulgent Genetics (FLGT) Stock Price Today?
The Fulgent Genetics stock price today is 19.15 USD.
What Stock Exchange Does Fulgent Genetics Trade On?
Fulgent Genetics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Fulgent Genetics?
The stock symbol for Fulgent Genetics is "FLGT."
What Is the Fulgent Genetics Market Cap?
As of today, Fulgent Genetics market cap is 524.44M USD.
What Is Fulgent Genetics's Earnings Per Share (TTM)?
The Fulgent Genetics EPS (TTM) is -2.81.
When Is the Next Fulgent Genetics Earnings Date?
Fulgent Genetics will release its next earnings report on Nov 06, 2026.
From a Technical Analysis Perspective, Is FLGT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Fulgent Genetics Stock Split?
Fulgent Genetics has split 0 times.
How Many Employees Does Fulgent Genetics Have?
Fulgent Genetics has 1315 employees.
What is the current trading status of Fulgent Genetics (FLGT)?
As of Aug 11, 2026, Fulgent Genetics (FLGT) is trading at a price of 19.15 USD, with a previous close of 19.06 USD. The stock has fluctuated within a day range of 19.03 USD to 19.28 USD, while its 52-week range spans from 13.46 USD to 31.04 USD.
What Is Fulgent Genetics (FLGT) Price Target According to Analysts?
The average 12-month price target for Fulgent Genetics is 19.00 USD, with a high estimate of 19 USD and a low estimate of 19 USD. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an -0.78% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.